{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:12:59Z","timestamp":1774116779028,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.mehy.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T03:17:27Z","timestamp":1460258247000},"page":"20-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0804-6292","authenticated-orcid":false,"given":"Theodoros","family":"Karampitsakos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2016.04.008_b0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"13","key":"10.1016\/j.mehy.2016.04.008_b0010","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The asthma\u2013COPD overlap syndrome","volume":"373","author":"Drazen","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.mehy.2016.04.008_b0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thoraxjnl-2014-206740","article-title":"Asthma-COPD overlap 2015: now we are six","volume":"70","author":"Gibson","year":"2015","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.mehy.2016.04.008_b0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.93.04040479","article-title":"The Dutch hypothesis (chronic non-specific lung disease) revisited","volume":"4","author":"Sluiter","year":"1991","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.mehy.2016.04.008_b0025","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.07-1561","article-title":"Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season","volume":"133","author":"Kostikas","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.mehy.2016.04.008_b0030","unstructured":"Diagnosis of diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD overlap syndrome (ACOS) \u2013 Based on the Global Strategy for Asthma Management and Prevention and the Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease <ACOS_2015.pdf>."},{"issue":"7","key":"10.1016\/j.mehy.2016.04.008_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arbres.2012.04.001","article-title":"Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish society of pulmonology and thoracic surgery","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"issue":"5","key":"10.1016\/j.mehy.2016.04.008_b0040","doi-asserted-by":"crossref","first-page":"e62985","DOI":"10.1371\/journal.pone.0062985","article-title":"The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population","volume":"8","author":"de Marco","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.mehy.2016.04.008_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/02770903.2011.555576","article-title":"Overlap syndrome of asthma and COPD predicts low quality of life","volume":"48","author":"Kauppi","year":"2011","journal-title":"J Asthma"},{"key":"10.1016\/j.mehy.2016.04.008_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1465-9921-12-127","article-title":"The clinical features of the overlap between COPD and asthma","volume":"12","author":"Hardin","year":"2011","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.mehy.2016.04.008_b0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.rmed.2013.03.007","article-title":"Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status","volume":"107","author":"Miravitlles","year":"2013","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.mehy.2016.04.008_b0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1164\/rccm.200203-183OC","article-title":"Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease","volume":"167","author":"Fabbri","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.mehy.2016.04.008_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/15412555.2013.831061","article-title":"Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma","volume":"11","author":"Rhee","year":"2014","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.mehy.2016.04.008_b0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1378\/chest.13-0622","article-title":"Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma","volume":"145","author":"Menezes","year":"2014","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.mehy.2016.04.008_b0075","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1183\/09031936.00118912","article-title":"Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice","volume":"41","author":"Miravitlles","year":"2013","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.mehy.2016.04.008_b0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1164\/rccm.200203-183OC","article-title":"Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease","volume":"167","author":"Fabbri","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2016.04.008_b0085","first-page":"1","article-title":"Asthma COPD overlap syndrome on CT densitometry: a distinct phenotype from COPD","author":"Gao","year":"2016","journal-title":"COPD"},{"key":"10.1016\/j.mehy.2016.04.008_b0090","article-title":"The role of flow-independent exhaled nitric oxide parameters in the assessment of airway diseases","author":"Paraskakis","year":"2015","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.mehy.2016.04.008_b0095","first-page":"88","article-title":"Exhaled nitric oxide and the management of childhood asthma\u2013yet another promising biomarker \u201chas been\u201d or a misunderstood gem","volume":"16","author":"Turner","year":"2015","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.mehy.2016.04.008_b0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/COPD.S44552","article-title":"Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study","volume":"9","author":"Donohue","year":"2014","journal-title":"Int J Chronic Obstructive Pulm Dis"},{"issue":"3","key":"10.1016\/j.mehy.2016.04.008_b0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.09-2090","article-title":"Exhaled nitric oxide in pulmonary diseases: a comprehensive review","volume":"138","author":"Barnes","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.mehy.2016.04.008_b0110","doi-asserted-by":"crossref","first-page":"271918","DOI":"10.1155\/2014\/271918","article-title":"Exhaled nitric oxide as a biomarker in COPD and related comorbidities","volume":"2014","author":"Malerba","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.mehy.2016.04.008_b0115","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2147\/COPD.S88274","article-title":"Biomarker-based detection of asthma\u2013COPD overlap syndrome in COPD populations","volume":"10","author":"Tamada","year":"2015","journal-title":"Int J Chronic Obstructive Pulm Dis"},{"key":"10.1016\/j.mehy.2016.04.008_b0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2011.00036","article-title":"Improvement of airflow limitation by fluticasone propionate\/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?","volume":"2","author":"Akamatsu","year":"2011","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2016.04.008_b0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1843.2010.01711.x","article-title":"Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations","volume":"15","author":"Antus","year":"2010","journal-title":"Respirology (Carlton, Vic)"},{"issue":"7","key":"10.1016\/j.mehy.2016.04.008_b0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.rmed.2004.12.008","article-title":"The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease","volume":"99","author":"Zietkowski","year":"2005","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.mehy.2016.04.008_b0135","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.mehy.2016.04.008_b0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2010.10.015","article-title":"Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control","volume":"105","author":"Kostikas","year":"2011","journal-title":"Respir Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716300287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716300287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T16:19:54Z","timestamp":1718468394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716300287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"alternative-id":["S0306987716300287"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.04.008","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}